Business Wire
10 Jun 2026, 00:30 UTC · 10h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Top 2 movers · tap to explore
What the story claims
1 claim · each scored for market impact
Aldeyra Therapeutics has appointed Darlene Deptula-Hicks to its board of directors. — Board appointments are generally neutral to slightly positive as they provide governance expertise, but rarely trigger significant price movements unless the individual is a high-profile catalyst for a merger or turnaround.
+0.10Which stocks this story touches
The company appointed an experienced industry veteran to its board of directors.
Continue reading
6 related stories
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
PRNewsWire
3h ago
